MBA, has more than 30 years of experience in the pharmaceutical industry and has held executive commercial roles at companies such as Danone Medical Nutrition, Orion Pharma, Astra Zeneca and Pharmacia.Cernelle’s CEO since August 2015.
Björn ArnsvikHead of Facilities & EHS
MSc Mech Eng., has over 30 years of experience in the pharmaceutical industry and has held management positions at companies such as Astra Zeneca, Pharmacia and Thermo Fisher Scientific. Björn joined Cernelle in 2016.
MSc Economics and an Executive MBA, has more than 20 years of experience in managerial positions in various industries, including medicine technology and among others from companies such as Nolato and Enzymatica. Fredrik joined Cernelle in 2019.
Anette Victor MendesHead of Quality Assurance
MSc Chem Eng, has almost 30 years of experience of the pharmaceutical industry and Quality Assurance at companies such as AstraZeneca and Recipharm. Anette joined Cernelle in 2023
Matilda AhlgrenHead of Quality Control & Development
BSc Chemical Eng., has over 15 years of experience in the pharmaceutical industry in different roles both in R&D and Supply Chain at companies such as Pharmacia and Johnson & Johnson. Matilda joined Cernelle in 2019
Sido KarlssonHead of Operations
Engineer, has more than 25 years of experience in the phamaceutical and medical devices industries, with leading roles in quality and production in companies such as AstraZeneca, NovoNordisk and Straumann. Sido joined Cernelle in 2023
Dr Hans FeldmeierChairman of the Executive Committee
Pharmacist, has more than 35 years of experience in the pharmaceutical industry and has held executive commercial roles at companies such as; Berlin-Chemie AG (Menarini Group), Schering AG, and Dermapharm AG. Acting CEO of Dermapharm SE since 2018. Dermapharm AG acquired AB Cernelle December 1st 2021.
Dörte MünsterMember of the Executive Committee
Has more than 30 years of experience within the pharmaceutical industry.
She joined Strathmann GmbH & Co. KG in 1988, as Head of the Supply Chain Division.
Acting CEO since 2018, when Dermapharm acquired the company.
Ken TineboMember of the Executive Committee
Ken Tinebo, MBA, has more than 30 years of experience in the pharmaceutical industry and has held executive commercial roles at companies such as Danone Medical Nutrition, Orion Pharma, Astra Zeneca and Pharmacia.
Cernelle’s CEO since August 2015.
If you continue to use this site, we will assume that you accept it.
A cookie is a text file that is stored on your device. Some information obtained through these cookies is shared with third parties.